TrialCancer immunology, immunotherapy : CII2010

Dynamic monitoring the TCR CDR3 spectratypes in patients with metastatic CRC treated with a combination of bevacizumab, irinotecan, fluorouracil, and leucovorin.

Wei Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.